Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001102624-15-000225
Filing Date
2015-02-13
Accepted
2015-02-13 17:07:20
Documents
7
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS, INC. 10-K/A aeolus10k.htm 10-K/A 36136
  Complete submission text file 0001102624-15-000225.txt   3924041

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT aols-20140930.xml EX-101.INS 649487
3 XBRL TAXONOMY EXTENSION SCHEMA aols-20140930.xsd EX-101.SCH 48932
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20140930_cal.xml EX-101.CAL 34225
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20140930_def.xml EX-101.DEF 111428
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20140930_lab.xml EX-101.LAB 333443
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20140930_pre.xml EX-101.PRE 228155
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50481 | Film No.: 15616101
SIC: 2834 Pharmaceutical Preparations